Interne link ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10 mei 31, 2017 om 11:00 AM UTC
Interne link ProQR remembers co-founder Henri Termeer after his unexpected passing mei 15, 2017 om 11:00 AM UTC
Interne link ProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leber’s Congenital Amaurosis Type 10 (LCA 10) and Usher Syndrome mei 01, 2017 om 11:00 AM UTC
Interne link ProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 Patients april 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at the Deutsche Bank Health Care Conference april 20, 2017 om 11:00 AM UTC
Interne link ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU april 03, 2017 om 11:00 AM UTC
Interne link ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer maart 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in March maart 01, 2017 om 12:00 PM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update februari 28, 2017 om 12:00 PM UTC
Interne link On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day februari 27, 2017 om 12:00 PM UTC
Interne link ProQR to Present at the LEERINK Partners Global Healthcare Conference februari 07, 2017 om 12:00 PM UTC